134 related articles for article (PubMed ID: 29939508)
1. Cost sharing for antiepileptic drugs: medication utilization and health plan costs.
Joyce NR; Fishman J; Green S; Labiner DM; Wild I; Grabowski DC
Am J Manag Care; 2018 Jun; 24(6):e183-e189. PubMed ID: 29939508
[TBL] [Abstract][Full Text] [Related]
2. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
Klepser DG; Huether JR; Handke LJ; Williams CE
J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
[TBL] [Abstract][Full Text] [Related]
3. The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.
Spargo A; Yost C; Squires P; Raju A; Schroader B; Brown JD
J Manag Care Spec Pharm; 2021 May; 27(5):554-564. PubMed ID: 33908275
[No Abstract] [Full Text] [Related]
4. Employer drug benefit plans and spending on prescription drugs.
Joyce GF; Escarce JJ; Solomon MD; Goldman DP
JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
[TBL] [Abstract][Full Text] [Related]
6. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
Harrison RF; Fu S; Sun CC; Zhao H; Lu KH; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2021 Jul; 225(1):68.e1-68.e11. PubMed ID: 33549538
[TBL] [Abstract][Full Text] [Related]
7. The Association between Type of Insurance Plan, Out-of-Pocket Cost, and Adherence to Antihypertensive Medications in Medicare Supplement Insurance Enrollees.
Zhang D; Xu J; Hall DB; Chen X; Chen M; Divers J; Wei J; Rajbhandari-Thapa J; Wright DR; Arabadjian M; Young HN
Am J Hypertens; 2024 May; ():. PubMed ID: 38727326
[TBL] [Abstract][Full Text] [Related]
8. Association of Financial Integration Between Physicians and Hospitals With Commercial Health Care Prices.
Neprash HT; Chernew ME; Hicks AL; Gibson T; McWilliams JM
JAMA Intern Med; 2015 Dec; 175(12):1932-9. PubMed ID: 26501217
[TBL] [Abstract][Full Text] [Related]
9. Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States.
Fishman J; Martin M; Labiner DM; Lew CR; Johnson BH
Epilepsy Behav; 2019 Oct; 99():106331. PubMed ID: 31399339
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries.
Ip Q; Malone DC; Chong J; Harris RB; Labiner DM
Epilepsy Behav; 2018 Mar; 80():208-214. PubMed ID: 29414554
[TBL] [Abstract][Full Text] [Related]
11. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
[TBL] [Abstract][Full Text] [Related]
12. Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition.
Feng K; Russo M; Maini L; Kesselheim AS; Rome BN
JAMA Health Forum; 2024 Mar; 5(3):e235429. PubMed ID: 38551589
[TBL] [Abstract][Full Text] [Related]
13. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
Leopold C; Wagner AK; Zhang F; Lu CY; Earle CC; Nekhlyudov L; Ross-Degnan D; Wharam JF
Breast Cancer Res Treat; 2018 Sep; 171(2):449-459. PubMed ID: 29855813
[TBL] [Abstract][Full Text] [Related]
14. Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.
Yeung K; Barthold D; Dusetzina SB; Basu A
N Engl J Med; 2020 Aug; 383(6):558-566. PubMed ID: 32757524
[TBL] [Abstract][Full Text] [Related]
15. Out-of-Pocket Spending for Asthma-Related Care Among Commercially Insured Patients, 2004-2016.
Sinaiko AD; Gaye M; Wu AC; Bambury E; Zhang F; Xu X; Wharam JF; Galbraith AA
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4324-4331.e7. PubMed ID: 34481128
[TBL] [Abstract][Full Text] [Related]
16. Designing a Value-Based Formulary for a Commercial Health Plan: A Simulated Case Study of Diabetes Medications.
Chen Y; Loucks AR; Sullivan SD; Pearson SD; Kent D; Yeung K
Value Health; 2023 Jul; 26(7):1022-1031. PubMed ID: 36796479
[TBL] [Abstract][Full Text] [Related]
17. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
18. How Have Patient Out-of-pocket Costs for Common Outpatient Orthopaedic Foot and Ankle Surgical Procedures Changed Over Time? A Retrospective Study From 2010 to 2020.
Goldfarb SI; Xu AL; Gupta A; Mun F; Durand WM; Gonzalez TA; Aiyer AA
Clin Orthop Relat Res; 2024 Feb; 482(2):313-322. PubMed ID: 37498201
[TBL] [Abstract][Full Text] [Related]
19. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic burden of breakthrough seizures.
Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
